Acelity L.P. Inc., is a privately held medical device company. It is a non-operating holding company whose wholly owned subsidiaries develop wound therapeutics and regenerative medicine products. The advanced wound therapeutics business is conducted by Kinetic Concepts and its subsidiaries, including Systagenix, and the regenerative medicine business is conducted by LifeCell.
Acelity's products are available in more than 75 countries. The company employs more than 5,500 people around the world. The company reported $1.8 billion in annual revenue globally in 2013.